Biotech company remains strongest performer in S&P 500 over past year
https://www.ft.com/content/05ce7a1d-0d7e-434a-bcea-e8239dcde17a?syn-25a6b1a6=1
Moderna swings to profit as momentum for cancer vaccine builds
By The Best News Network
November 6, 2026
